23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...
Millions of people have sent their DNA to be analyzed by 23andMe in order to learn their genealogy and risk for certain ...
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported its latest quarterly loss, shedding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback